NanoViricides Inc (NNVC)
NanoViricides is a nano-biopharmaceutical research and development company focusing on the discovery, development, and commercialization of drugs for viral infections using its nanomedicines technology. Co.'s drug programs are: CoronaVirus Program; HerpeCide Program, which includes NV-HHV-1 Dermal Topical, NV-HHV-1 Oral Gummies, Oral Syrup, and Injectable Solution, for Injection or Infusion; Monkeypox Treatment; Adenovirus 71 Treatment; HerpeCide Program Expansion Drug Projects; HIVCide ; FluCide Broad-Spectrum Anti-Influenza nanoviricide; Nanoviricide Eye Drops; DengueCide; Other Nanoviricides Drug Projects; and Long Term Projects.
Company Name: |
NanoViricides Inc |
Website: |
www.nanoviricides.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding NNVC: |
2 |
Total Market Value Held by ETFs: |
$522909 |
Total Market Capitalization: |
$14.00M |
% of Market Cap. Held by ETFs: |
3.74% |
|
|
April 18, 2024 3:33 PM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|